Table 1 Baseline demographic and clinical characteristics pertaining to all the patients
From: Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Characteristics | N = 21 |
|---|---|
n (%)/Md ± IQR [range] | |
Age (y) | 51.00 ± 18.50 [43.00–61.50] |
Age | |
≦ 50 | 10 (47.6) |
> 50 | 11 (52.4) |
Sex | |
Male | 6 (28.6) |
Female | 15 (71.4) |
Laterality | |
OD | 13 (61.9) |
OS | 8 (38.1) |
AXL (mm) | 29.34 ± 2.72 [28.08–30.80] |
AXL (mm) | |
< 30 | 13 (61.9) |
≧ 30 | 8 (38.1) |
CNV location (mm) | |
Subfoveal | 16 (76.2) |
Juxtafoveal < 200 | 5 (23.8) |
Number of injections | 2.00 ± 1.00 [1.00–2.00] |
Number of injections and patients | |
Once | 10 (47.6) |
Twice | 9 (42.9) |
Three times | 2 (9.5) |